Pulmonary Cytopathology: Current and Future Impact on Patient Care

Area of Science:

• Pulmonology
• Oncology
• Cytopathology

Background:

• Lung cancer diagnosis often relies on small biopsy specimens.
• Primary resection may not be feasible at diagnosis, necessitating comprehensive information from biopsies.
• Expanding diagnostic and predictive markers require updated cytopathology practices.

Purpose of the Study:

• To review current requirements for handling small lung biopsy specimens.
• To guide cytopathologists on specimen acquisition, handling, and testing.
• To emphasize the importance of deriving all necessary information from limited biopsy material.

Main Methods:

• Review of established and emerging methods for obtaining lung cytologic specimens.
• Discussion of requirements for ancillary testing, including molecular diagnostics.
• Analysis of reporting standards for diagnostic, predictive, and prognostic information.

Main Results:

• Small lung biopsy specimens are crucial for comprehensive cancer evaluation.
• Cytopathologists need to be proficient in molecular and ancillary testing.
• Standardized practices are essential for accurate interpretation of cytologic specimens.

Conclusions:

• Optimizing the use of small lung biopsies is critical for lung cancer management.
• Familiarity with updated testing and reporting is essential for cytopathologists.
• Accurate diagnostic, predictive, and prognostic information can be obtained from cytologic specimens.